Loading...

APC anti-mouse TER-119/Erythroid Cells Antibody

Pricing & Availability
Clone
TER-119 (See other available formats)
Regulatory Status
RUO
Other Names
Ly-76
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
TER-119_APC_122107
C57BL/6 bone marrow cells stained with TER-119 APC and anti-mouse CD45 FITC
  • TER-119_APC_122107
    C57BL/6 bone marrow cells stained with TER-119 APC and anti-mouse CD45 FITC
See APC spectral data
Cat # Size Price Quantity Check Availability Save
116211 25 µg 36€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
116212 100 µg 111€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

The TER-119 antigen is a 52 kD glycophorin A-associated protein, also known as Ly-76. TER-119 is an erythroid-specific antigen expressed on early proerythroblasts to mature erythrocytes, but not on erythroid colony-forming cells (BFU-E, blast-forming unit erythroid, or CFU-E, colony-forming unit erythroid).

Product Details
Technical Data Sheet (pdf)

Product Details

Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Day-14 fetal liver cells from a C57BL/6 mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with APC under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Red Laser (633 nm)
Application Notes

The TER-119 antibody is useful for distinguishing erythrocytes and cells in the erythroid lineage. Additional reported applications (for the relevant formats) include: immunoprecipitation1, Western blotting1, complement-mediated cytotoxicity3, and immunohistochemical staining of acetone-fixed frozen sections and formalin-fixed paraffin-embedded sections. Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 116253-116258).

Application References
  1. Kina T, et al. 2000. Br. J. Haematol. 109:280. (IP, WB)
  2. Vannucchi AM, et al. 2000. Blood 95:2559.
  3. Maraskovsky E, et al. 1996. J. Exp. Med. 184:1953. (CMCD)
  4. Grisendi S, et al. 2005. Nature 437:147. (FC)
  5. Bourdeau A, et al. 2007. Blood 109:4220.
  6. Chappaz S, et al. 2007. Blood 110:3862. (FC)
  7. Heuser M, et al. 2007. Blood 110:1639. (FC)
  8. Gough SM, et al. 2014. Cancer Discov. 4:564. PubMed
Product Citations
  1. Koury D, et al. 2017. Int J Parasitol. 10.1016/j.ijpara.2017.05.009. PubMed
  2. Pal B, et al. 2017. Nat Commun.. 10.1038/s41467-017-01560-x. PubMed
  3. Lam J, et al. 2018. Nat Commun. 9:2418. PubMed
  4. Wang L, et al. 2018. Bone Res. 6:22. PubMed
  5. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  6. Tanimura N et al. 2018. Developmental cell. 46(5):581-594 . PubMed
  7. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  8. Parada-Kusz M, et al. 2018. Dis Model Mech. 11:. PubMed
  9. Wang H, et al. 2019. J Clin Invest. 129:598. PubMed
  10. Stivala S, et al. 2019. J Clin Invest. 130:1596. PubMed
  11. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  12. Goldstein JM et al. 2019. Cell reports. 27(4):1254-1264 . PubMed
  13. Maroni G, et al. 2019. Int J Mol Sci. 20. PubMed
  14. Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed
  15. Samarchith P Kurup et al. 2019. Cell host & microbe. 25(4):565-577 . PubMed
  16. Carmody C et al. 2019. Endocrinology. 160(5):1205-1222 . PubMed
  17. Fu NY, et al. 2018. Dev Cell. 47:629. PubMed
  18. Riffelmacher T et al. 2017. Immunity. 47(3):466-480 . PubMed
  19. Yu VWC, et al. 2017. Cell. 168:944. PubMed
  20. Yu VWC et al. 2016. Cell. 167(5):1310-1322 . PubMed
  21. Mourao L, et al. 2019. Sci Rep. 0.991666667. PubMed
  22. Hidalgo San Jose L, et al. 2020. Cell Rep. 30:69. PubMed
  23. Lutzmann M, et al. 2019. Cell Rep. 28:2851. PubMed
  24. Siddique SM, et al. 2019. Sci Rep. 9:13977. PubMed
  25. Li G, et al. 2020. J Clin Invest. 130:1233. PubMed
  26. Ray S, et al. 2020. J Biol Chem. 295:7113. PubMed
  27. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  28. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  29. Shin JJ, et al. 2020. Cell Rep. 32:108093. PubMed
  30. Liu Z, et al. 2020. Cell. 178(6):1509-1525.e19.. PubMed
  31. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  32. Yeo SK, et al. 2020. eLife. 9:e58810.. PubMed
  33. Engelbrecht E, et al. 2020. eLife. 9:e52690.. PubMed
  34. Bilodeau M, et al. 2009. PLoS One. 4:e7500. PubMed
  35. Guihard S, et al. 2010. Blood. 115:3686. PubMed
  36. Liu J, et al. 2012. PLoS One. 7:e44044. PubMed
  37. Lafkas D, et al. 2013. J Cell Biol. 203:47. PubMed
  38. Song J, et al. 2014. Exp Cell Res. 327:123. PubMed
  39. Khoriaty R, et al. 2014. Mol Cell Biol. 34:3721. PubMed
  40. Yin Y, et al. 2016. J Biol Chem. 291: 6923 - 6935. PubMed
  41. Yeo S, et al. 2016. Cancer Res . 76: 3397 - 3410. PubMed
  42. Rowe R, et al. 2016. J Exp Med. 213: 1497 - 1512. PubMed
  43. Cambridge E, et al. 2017. Exp Hematol. 45:64-68.e5. PubMed
  44. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  45. Nosho S, et al. 2020. Int J Mol Sci. 21:00. PubMed
  46. Liu P, et al. 2020. Genome Res. 30:1655. PubMed
  47. Markworth JF, et al. 2020. JCI Insight. 5:00. PubMed
  48. Wang H, et al. 2020. JCI Insight. 5:00. PubMed
  49. Werner MT, et al. 2020. J Biol Chem. 295:1898. PubMed
  50. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  51. Nayak RR, et al. 2021. Cell Host Microbe. 29(3):362-377.e11. PubMed
  52. Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed
  53. Chappaz S, et al. 2021. Cell Reports. 36(3):109430. PubMed
  54. Larouche JA, et al. 2021. eLife. 0.416666666666667. PubMed
  55. Kruta M, et al. 2021. Cell Stem Cell. :. PubMed
  56. Yanagida K, et al. 2020. Dev Cell. 779:52. PubMed
  57. Chen C, et al. 2020. Cell Rep. 2136:30. PubMed
  58. Crowe JL, et al. 2020. Proc Natl Acad Sci U S A. 22953:117. PubMed
  59. Shcherbina A, et al. 2020. Cell Rep. 32:107964. PubMed
  60. Maller O, et al. 2020. Nat Mater. 20:548. PubMed
  61. Pal B, et al. 2021. Breast Cancer Res. 23:69. PubMed
  62. Perez E, et al. 2020. J Immunol. 205:2489. PubMed
  63. Liu S, et al. 2021. Mol Ther. 29:1918. PubMed
  64. Symeonidou V, et al. 2021. Cell Rep. 37:109900. PubMed
  65. Maeda K, et al. 2021. Pathogens. 10:. PubMed
  66. Li C, et al. 2021. Mol Ther. 29:822. PubMed
  67. Murray CW, et al. 2022. Nat Commun. 13:1090. PubMed
  68. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  69. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  70. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
  71. Magee JA, et al. 2021. Stem Cell Reports. 16:20. PubMed
  72. Nishina T, et al. 2021. Nat Commun. 12:2281. PubMed
  73. Negretti NM, et al. 2021. Development. 148:. PubMed
  74. Awida Z, et al. 2021. Int J Mol Sci. 23:. PubMed
  75. Long JT, et al. 2022. Elife. 11:. PubMed
  76. Yang D, et al. 2022. Cell. 185:1905. PubMed
  77. Sá da Bandeira D, et al. 2022. Cell Rep. 40:111114. PubMed
  78. Rai S, et al. 2022. Nat Commun. 13:5346. PubMed
  79. Schmidts A, et al. 2020. J Immunother Cancer. 8:. PubMed
  80. Dagher T, et al. 2021. J Exp Med. 218:. PubMed
  81. Hou Y, et al. 2021. Sci Transl Med. 13:. PubMed
  82. Saleiro D, et al. 2022. Nat Commun. 13:1750. PubMed
  83. Haase C, et al. 2022. Nat Methods. 19:1622. PubMed
  84. Pezoldt J, et al. 2022. Nat Commun. 13:7227. PubMed
  85. Aimaitijiang A, et al. 2022. Genes Cells. 27:25. PubMed
  86. Kozuki S, et al. 2022. Genes Cells. 27:192. PubMed
  87. Yousefi M, et al. 2022. Cancer Res. 82:1589. PubMed
  88. Tátrai P, et al. 2022. EMBO J. 41:e108739. PubMed
  89. Cattaneo P, et al. 2022. Nat Commun. 13:7444. PubMed
  90. Wu Q, et al. 2023. Cell Rep. 42:112057. PubMed
  91. Leick MB, et al. 2022. Cancer Cell. 40:494. PubMed
  92. Ray S, et al. 2022. Elife. 11:. PubMed
  93. Awida Z, et al. 2022. Int J Mol Sci. 23:. PubMed
  94. Gómez-Salinero JM, et al. 2022. Nat Cardiovasc Res. 1:882. PubMed
  95. Peng YJ, et al. 2023. Development. 150:. PubMed
  96. Kawai H, et al. 2023. JBMR Plus. 7:e10722. PubMed
  97. Kalgudde Gopal S, et al. 2023. Nat Commun. 14:3020. PubMed
  98. Sucre JM, et al. 2023. JCI Insight. . PubMed
  99. Menolfi D, et al. 2023. Nat Commun. 14:3618. PubMed
RRID
AB_313712 (BioLegend Cat. No. 116211)
AB_313713 (BioLegend Cat. No. 116212)

Antigen Details

Structure
Associated with glycophorin A, 52 kD
Distribution

Early proerythroblast to mature erythrocyte, but not BFU-E and CFU-E

Cell Type
Erythrocytes
Biology Area
Immunology
Antigen References

1. Kina T, et al. 2000. Br. J. Haematol. 109:280.
2. Ikuta K, et al. 1990. Cell 62:863.
3. Osawa M, et al. 1996. Weir's Handbook of Experimental Immunology. Vol. 2 pp. 66.1-66.5.

Gene ID
104231 View all products for this Gene ID
UniProt
View information about TER-119 on UniProt.org

Related FAQs

There are no FAQs for this product.
Go To Top Version: 2    Revision Date: 12/04/2013

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account